Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pharmacogenetics

Anti-TNF therapy in RA—towards personalized medicine?

Nature Reviews Rheumatology volume 7, pages 136–138 (2011)Cite this article

Subjects

A substantial proportion of patients with rheumatoid arthritis do not respond to tumor necrosis factor blocking therapy. Results of a large genome-wide association study demonstrate evidence of novel genetic factors that determine response to treatment, which could provide a basis for individualizing therapy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Plant, D. et al. Genome-wide association study of genetic predictors of anti-tumour necrosis factor (TNF) treatment in rheumatoid arthritis (RA) identifies associations with polymorphisms at seven loci. Arthritis Rheum. doi:10.1002/art.30130.

  2. Hyrich, K. L., Watson, K. D., Silman, A. J., Symmons, D. P. & British Society for Rheumatology Biologics Register. Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 45, 1558–1565 (2006).

    Article  CAS  Google Scholar 

  3. van Baarsen, L. G. et al. Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis. Genes Immun. 11, 622–629 (2010).

    Article  CAS  Google Scholar 

  4. Hueber, W. et al. Blood autoantibody and cytokine profiles predict response to anti-TNF therapy in rheumatoid arthritis. Arthritis Res. Ther. 11, R76 (2009).

    Article  Google Scholar 

  5. Marsal, S. & Julià, A. Rheumatoid arthritis pharmacogenomics. Pharmacogenomics 11, 617–619 (2010).

    Article  CAS  Google Scholar 

  6. Coenen, M. J. et al. Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis. Pharmacogenomics 8, 761–773 (2007).

    Article  CAS  Google Scholar 

  7. Cui, J. et al. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor α therapy. Arthritis Rheum. 62, 1849–1861 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. van Baarsen, L. G. et al. Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. Arthritis Res. Ther. 12, R11 (2010).

    Article  Google Scholar 

  9. Gonzales-Gay, M. A., Gonzalez-Juanatey, C., Vazquez-Rodriquez, T. R., Miranda-Filloy, J. A. & Llorca, J. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-α therapy. Ann. NY Acad. Sci. 1193, 153–159 (2010).

    Article  Google Scholar 

  10. Jakobsdottir, J., Gorin, M. B., Conley, Y. P., Ferrell, R. E. & Weeks, D. E. Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet. 5, e1000337 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology and Rheumatology, VU University Medical Center, Section of Inflammatory Disease Profiling, P.O. Box 7057, CCA2.60, 1007MB, Amsterdam, The Netherlands

    Cornelis L. Verweij

Authors
  1. Cornelis L. Verweij
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

C. L. Verweij is a patent holder/applicant for a VU University Medical Center product.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verweij, C. Anti-TNF therapy in RA—towards personalized medicine?. Nat Rev Rheumatol 7, 136–138 (2011). https://doi.org/10.1038/nrrheum.2011.13

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2011.13

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing